Edwards Lifesciences Corporation

NYSE:EW

65.84 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Assets:
Current Assets:
Cash & Cash Equivalents 1,144769862.81,183.21,179.1714.1818.3930.1718.4653.8420.4310.9171.2396.1334.1218.7141.8182.8178.648.961.134.248280
Short Term Investments 500.5446.3604219.4337.8242.4519.2341506.3785516.5210.5279.3008.149.400000000
Cash and Short Term Investments 1,644.51,215.31,466.81,402.61,516.9956.51,337.51,271.11,224.71,438.8936.9521.4450.5396.1334.1226.8191.2182.8178.648.961.134.2482813
Net Receivables 836.9699.1664.9602.8599.1537.3462.2414.6344.1325328347.5320.7302.5272.1204.7145.3127.1118.5119.4118.5108.4101129155
Inventory 1,168.2875.5726.7802.3640.9607554.9396.6339.9296.8308.9281261.3203.6165.9151.8152.6142.1131.5127.7120.5111.88773169
Other Current Assets 239.3195.9237.1208.2168131.8116.9111.894.1121.771.85757.143.135.135.53779.610.58.26.423.4201519
Total Current Assets 4,035.73,095.83,180.73,0912,9842,286.92,532.12,2402,047.92,294.61,725.81,291.91,168.51,032.6889.2691.9581.7531.6514.2367.5360.2326.4293282356
Non-Current Assets:
Property, Plant & Equipment, Net 1,843.41,725.11,638.71,489.41,140.4867.5679.7580482.5442.9421.6373.3304.3269.8252230.1228.2213201.9201.7209.9209.4178183226
Goodwill 1,253.51,164.31,167.91,173.21,167.71,112.21,126.5626.1628.3376385.4384.7349.8315.2315.2315.7350.3337.7337.7337.7338.2333.840200
Intangible Assets 428.4285.2323.6331.4336.5343.2468204.8205.423.457.26766.967.186.796.9122.5116.1475.4490.3419.2395.705110
Goodwill and Intangible Assets 1,681.91,449.51,491.51,504.61,504.21,455.41,594.5830.9833.7399.4442.6451.7416.7382.3401.9412.6472.8453.8475.4490.3419.2395.7402511839
Long Term Investments 583.91,2391,834.2801.6585.5506.3567532.1379.9240.921.921.121.82522.314.734201120.635.423.59301
Tax Assets 754.6484246.7230.9172.2174214.3203.8180.591.570.147.32044.537.137.713.814.511.522.359.338.81800
Other Non-Current Assets 463.7299.1110.8119.6101.833.6108.9123.2134.85542.736.249.2131313.214.613.915.110.317.414.4-1111215
Total Non-Current Assets 5,327.55,196.75,321.94,146.13,504.13,036.83,164.42,2702,011.41,229.7998.9929.6812734.6726.3708.3763.4715.2714.9745.2741.2681.86808061,081
Total Assets 9,363.28,292.58,502.67,237.16,488.15,323.75,696.54,5104,059.33,524.32,724.72,221.51,980.51,767.21,615.51,400.21,345.11,246.81,229.11,112.71,101.41,008.29731,0881,437
Liabilities & Equity:
Current Liabilities:
Account Payables 201.4201.9204.5196.5180.4134116.697.163.958.248.474.78547.651.165.663.957.2194.2195.4167.2197.91831580
Short Term Debt 24.925.525.527.225.5059800000041.800150000001610
Tax Payables 122.396.299.568.3104.370.8139.741.24941.838.740.537.522.335.96.20370000000
Deferred Revenue 953.9484798.4630.9690.10633.100000022.300000000-18300
Other Current Liabilities 15.23113.939.36.4742.651.7435.4412.3376.2297.2272.7250.2226.1239.4192.9161.516900001830156
Total Current Liabilities 1,195.41,022.41,032.3893.9902.4876.61,399.4532.5476.2434.4345.6347.4335.2337.8290.5258.5375.4226.2194.2195.4167.2197.9184219156
Non-Current Liabilities:
Long Term Debt 670665.8664.8667.7653.3593.8438.4822.3599.9598.1593.1189.3150.4090.3175.561.7235.9316.1267.1255.8245.53103670
Deferred Revenue Non-Current 0000000000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000000000
Other Non-Current Liabilities 778.4797.6969.61,101.2784.1712.9864536.2480.1300.4226.8205.5157121.276.887.47335.328.822.143.325.4206257
Total Non-Current Liabilities 1,448.41,463.41,634.41,768.91,437.41,306.71,302.41,358.51,080898.5819.9394.8307.4121.2167.1262.9134.7271.2344.9289.2299.1270.933042957
Total Liabilities 2,643.82,485.82,666.72,662.82,339.82,183.32,701.81,8911,556.21,332.91,165.5742.2642.6459457.6521.4510.1497.4539.1484.6466.3468.8514648213
Equity:
Preferred Stock 0000000000000000000000000
Common Stock 650.5646.3642636.4218.1215.2212242.6239.1128.9126124.212011776.173.768.66765.664.262.660.259590
Retained Earnings 8,992.47,5906,068.14,5653,741.62,694.72,000.63,906.33,336.82,841.92,045.61,653.91,360.71,124906676.9548.6433.9303.4224.1222.4143.488103418
Accumulated Other Comprehensive Income/Loss -242.8-254.9-157.7-161.1-156-138.5-132.7-198.4-182.6-100.9-27.6-37.9-37.5-42.1-7.9-35.47.5-15.8-22.2-20.8-32.2-44.7261-27
Other Total Stockholders Equity -2,750.1-2,174.7-716.5-466344.6369914.8-1,331.5-890.2-678.5-584.8-260.9-105.3109.3183.7163.6210.3264.3343.2360.6382.3380.5286277833
Total Shareholders Equity 6,6505,806.75,835.94,574.34,148.33,140.42,994.72,6192,503.12,191.41,559.21,479.31,337.91,308.21,157.9878.8835749.4690628.1635.1539.44594401,224
Total Equity 6,719.45,806.75,835.94,574.34,148.33,140.42,994.72,6192,503.12,191.41,559.21,479.31,337.91,308.21,157.9878.8835749.4690628.1635.1539.44594401,224
Total Liabilities & Shareholders Equity 9,363.28,292.58,502.67,237.16,488.15,323.75,696.54,5104,059.33,524.32,724.72,221.51,980.51,767.21,615.51,400.21,345.11,246.81,229.11,112.71,101.41,008.29731,0881,437